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The external part of the globus pallidus (GPe) is a core nucleus of the basal ganglia (BG) whose activity is dis-
rupted under conditions of low dopamine release, as in Parkinson's disease. Current models assume decreased
dopamine release in the dorsal striatum results in deactivation of dorsal GPe, which in turn affects motor
expression via a regulatory effect on other nuclei of the BG. However, recent studies in healthy and pathological
animal models have reported neural dynamics that do not match with this view of the GPe as a relay in the BG
circuit. Thus, the computational role of the GPe in the BG is still to be determined. We previously proposed a
neural model that revisits the functions of the nuclei of the BG, and this model predicts that GPe encodes values
which are ampliﬁed under a condition of low striatal dopaminergic drive. To test this prediction, we used an fMRI
paradigm involving a within-subject placebo-controlled design, using the dopamine antagonist risperidone,
wherein healthy volunteers performed a motor selection and maintenance task under low and high reward
conditions. ROI-based fMRI analysis revealed an interaction between reward and dopamine drive manipulations,
with increased BOLD activity in GPe in a high compared to low reward condition, and under risperidone
compared to placebo. These results conﬁrm the core prediction of our computational model, and provide a new
perspective on neural dynamics in the BG and their effects on motor selection and cognitive disorders.Introduction
Pioneering studies (Albin et al., 1989, 1991; Alexander et al., 1986;
DeLong, 1983, 1990; Smith et al., 1998) investigating the function of the
basal ganglia (BG) proposed these interconnected nuclei play a funda-
mental role in action facilitation, and in the regulation of voluntary
movement. Subsequent local connectome analyses resulted in further
model developments (Frank, 2005, 2006; Gurney et al., 2004; Humphries
et al., 2006; Nambu, 2004), including the suggestion that biophysical
dysfunctions in the BG circuit might explain speciﬁc behavioural disor-
ders and diseases (Obeso et al., 2014). These models propose that the
output of the BG exerts a tonic inhibition of all motor commands to
mediate a gating function. This output activity combines information
conveyed through several converging pathways, termed direct, indirect
and hyperdirect. It is hypothesised that these pathways compete to
control activity of BG output nuclei, resulting in general inhibition or
selective disinhibition (Calabresi et al., 2014; Nelson and Kreitzer, 2014;TD, 2200 West Mockingbird Lan
. Fiore).Schroll and Hamker, 2013). The direct pathway is thought responsible
for motor facilitation and selective disinhibition and conveys cortical
information via striatal medium spiny neurons rich in D1 receptors, to
the output nuclei of substantia nigra pars reticulata (SNr) and globus
pallidus pars interna (GPi). The indirect pathway conveys cortical in-
formation via D2-enriched spiny neurons in the striatum to the globus
pallidus pars externa (GPe), which has efferent connections towards SNr,
GPi, sub-thalamic nucleus (STN), striatum and parafascicular thalamic
nucleus (Abdi et al., 2015; Gittis et al., 2014; Mastro et al., 2014). Finally,
the hyperdirect pathway bypasses the striatum as input structure, and
conveys cortical information to the SNr and GPi via the STN, establishing
a recurrent circuit with the GPe (Smith et al., 1998).
A classic view states that striatal dopamine (DA) release modulates
activity of the internal nuclei of BG, arbitrating the competition among
the converging pathways for the control of the output of the system
(Albin et al., 1989, 1991; DeLong, 1990; Frank, 2011). It is generally
assumed that low DA drive in the dorsal striatum, such as seen ine, Dallas, TX 75235, USA.
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signalling in D2-enriched striatum, which in turn causes decreased ac-
tivity in the GPe (Chan et al., 2011; Filion and Tremblay, 1991). In a
cascade effect, the suppression of activity in the GPe enhances activity in
the STN, and in the BG output nuclei SNr and GPi, to inhibit motor
expression. This model establishes a quasi-linear relationship between
striatal DA release, pathway activity and behaviour (e.g. see: Frank et al.,
2007; Nambu, 2004). Low DA activity is associated with increased in-
direct pathway signalling and motor suppression, while high DA activity
is associated with increased direct pathway activity and motoric facili-
tation (Obeso et al., 2008a, 2008b).
However, recent studies provide evidence that conﬂicts with both an
hypothesis of competing pathways and an assumption of a linear corre-
lation between striatal DA release and neural activity or resultant
behaviour (Calabresi et al., 2014; Nambu, 2008; Nelson and Kreitzer,
2014). Firstly, concurrent activity in direct and indirect pathways has
been found during motor initiation, highlighting the role played by the
indirect pathway in triggering contraversive movements (Tecuapetla
et al., 2014, 2016). Secondly, subthalamic deep brain stimulation ame-
liorates Parkinson's disease motor symptoms by over-activating STN,
whose signalling is already enhanced by low DA release (Fiore et al.,
2016; Galati et al., 2006; Hashimoto et al., 2003). Finally, the role played
by the GPe in the indirect pathway has been revisited (Gittis et al., 2014),
disputing an assumption that this nucleus functions as a relay between
D2-striatum and STN. In fact, the GPe is now seen as composed of het-
erogeneous neural populations (Abdi et al., 2015; Mallet et al., 2012;
Mastro et al., 2014; Mastro and Gittis, 2015; Saga et al., 2017) that ex-
press complex patterns of activity (Bevan et al., 2002; Brown, 2007;
Chiken and Nambu, 2016; Mallet et al., 2008a, 2008b), suggesting its
computational role in the BG also needs to be revisited.
Using a neural model, we have recently proposed a different
perspective on BG function and neural dynamics, with particular atten-
tion on the role played by the GPe and the indirect pathway. As in pre-
vious models of BG dynamics (see e.g.: Frank, 2011; Frank et al., 2007;
Gurney et al., 2001; Humphries et al., 2006; Mannella et al., 2013), we
assume cortical signals convey to the striatum different information
about action-state values. These signals compete among one another as
they are propagated through the BG pathways and are subject in turn to
modulation by striatal DA release. In our model, these competing signals
in the direct and indirect pathways are either compressed or ampliﬁed as
a function of striatal DA release (Fig. 1). Subsequently, the transformed
information in the BG pathways is integrated in the output nuclei and
propagated back to its origin in the cortex. Due to this recurrent circuitry,
information ampliﬁcation in the direct pathway results in increased
circuit gain, strong attractors and stable state transitions (Fiore et al.,
2014), whereas information ampliﬁcation in the indirect pathway results
in decreased circuit gain, shallow attractors and either metastable dy-
namics (Hauser et al., 2016) or oscillations (Fiore et al., 2016). This
change of perspective is essential to account for both the classic
DA-related coarse arbitration between suppression and facilitation of
motor and cognitive functions, as well as new data suggesting a more
complex and ﬁnely grained regulatory role for the indirect pathway
(Gittis et al., 2014; Tecuapetla et al., 2014, 2016; Vicente et al., 2016). In
particular, our simulations show the encoding of the cortical input in the
internal nuclei of the BG interacts with the striatal DA release, resulting
in non-linear dynamics and in broadening the set of the possible func-
tions and dysfunctions associated with BG gating. Crucially, our model
predicts that striatal DA modulation results in information compression
in the GPe, under basal or high DA drive, and information ampliﬁcation
in the GPe under reduced DA drive (Fig. 1). A similar interaction, but
with the opposite direction of information compression and ampliﬁca-
tion is predicted for the BG output nuclei (Fig. 1).
To test our predictions, we examined twenty-four healthy volunteers
performing a reward-based motor task during fMRI. We used a within-
subject comparison of behaviour and fMRI blood-oxygen-level depen-
dent (BOLD) activity in a 2 2 design where we manipulated DA drive250and perceived action-state values. We utilized this design to test the
phenomena of ampliﬁcation and compression of action-state value
encoding in the BG nuclei. In effect, we assessed BOLD activity in
response to different rewards associated with action execution under
conditions mimicking healthy and reduced DA release (as e.g. in Par-
kinson's disease). In particular, the model we test predicted the presence
of an interaction effect, as we expected to ﬁnd enhanced action-state
value differentiation in the GPe (signal ampliﬁcation) under a low DA
drive condition, induced by treatment with risperidone.
Materials and methods
Neural model
We used a simpliﬁed neural architecture (Fig. 1A) to illustrate how
DA release dynamically interact with action-state value representations
in the striatum, GPe, GPi and SNr. We assumed four inputs, kept constant
through the simulation (Fig. 1B), and representing the cortical encoding
of the values associated with actions performed under speciﬁc environ-
mental conditions, hence action-state values (cf. Sarsa algorithms as
introduced in: Rummery and Niranjan, 1994). These inputs are propa-
gated via parallel connectivity towards a layer of neural units repre-
senting the striatum. During the same time interval, a simulated release
of tonic DA gradually increases (Fig. 1C) as it reaches the striatal units.
These units respond in a different way to the incoming inputs and DA,
depending on the presence of either D1 and D2 receptors (Fig. 1D and E).
The resulting activity reaches via inhibitory connections the internal
nucleus GPe (Fig. 1F) and the output nuclei GPi and SNr (Fig. 1G), which
are also affected by the GPe, via inhibitory connections. For illustrative
purpose, this BG circuit has been simpliﬁed by considering the output
nuclei as identical (hence labelled GPi/SNr, Fig. 1G) and by using a
baseline positive activity in place of the excluded excitatory signal
derived by the sub-thalamic nucleus (for a more detailed version of the
model, see: Fiore et al., 2016; Hauser et al., 2016). The activity of all units
in this model is described in a continuous time differential equation (1) a
positive saturation transfer function (2):
τg _uj ¼ uj þ bj þ ðεþ λdÞ
X
wjiyi (1)
yj ¼

tanh

uj
þ (2)
where the action potential of a unit uj is updated at a pace determined by
the time constant τg , and depending on the value of a baseline bj (constant
per nucleus) and an input
P
wjiyi, weighed by ðεþ λdÞ. The two constants
ε and λ respectively regulate the amount of input signal that is inde-
pendent of the presence of DA (d in equation (1)), and the response of the
DA receptor. In the simulated striatum, λ¼ 2 and λ¼ -1.5 simulate D1
and D2 receptors respectively, whereas λ¼ 0 for all other units. The
model was developed using Matlab.Participants
24 healthy volunteers (17 females, 23 right handed), age 25.1 0.9,
weight 60.4 7.3 kg, were recruited for this study via an advertised
mailing list hosted by the Institute of Cognitive Neuroscience at Uni-
versity College London. The sample size was determined on the basis of a
comparison with previous studies targeting the BG nuclei under similar
experimental conditions, either by the same authors (Smittenaar et al.,
2017), or reported in literature (Bischoff-Grethe et al., 2015; Doll et al.,
2015; Golﬁnopoulos et al., 2011; Li et al., 2011; for a recent review, see:
Saga et al., 2017). Selection criteria included weight (inclusion range:
50 kg–70 kg) and age (inclusion range of 20–40 years). These criteria
were based on a previous study (Fiore et al., 2016) to enhance chances of
a consistent effect of the administered DA antagonist across subjects.
Participants taking any medication, or with a history of mental disorder
Fig. 1. Neural model and simulated neural dynamics. A) Schematic representation of the anatomic neural areas discussed in the paper (left) and graph illustrating the
simpliﬁed neural architecture used to simulate BG circuit dynamics (right). Four simulated sensorimotor or action-state values (B), putatively encoded in cortical
signals reaching the striatum, are constant during the whole simulation. Tonic DA release targeting the striatum (C) slowly increases during the simulation, affecting
the way the input is encoded in the striatum. Striatal D1-enriched units (D) amplify the differences among the inputs as a direct function of DA release. Conversely,
striatal D2-enriched units (E) show the higher differentiation under low DA release, as the input signals are compressed towards the end of the simulated time, in
association with high DA release. GPe (F) and GPi/SNr (G) receive the input after it is processed by D2 and D1 enriched striatum, respectively. Due to the inhibitory
afferent connections, the GPe mirrors the signal received from the D2 striatum. Finally, GPi/SNr receive conﬂicting inhibitory information from D1 striatum (direct
pathway) and GPe (indirect pathway), resulting in the compression of signal differences, at low dopamine release. The key prediction of this computational hypothesis
is further illustrated in the heatmaps for each BG nucleus, where we represent the differences in simulated neural activity between the encoding of high and low
action-state values. This difference is tested in our within-subject fMRI paradigm, as the model predicted increased High-Low differentiation in the GPe under a
condition characterised by low dopaminergic release, in comparison with basal or high dopaminergic conditions.
V.G. Fiore et al. NeuroImage 173 (2018) 249–257or drug abuse were excluded from the study. Subjects were asked to
avoid consumption of alcohol, coffee, tea, energy drink, or any similar
stimulant 12 h prior to each session, but they were not assessed with a
toxicology test. Informed consent was obtained from all participants,
who were made aware that they could quit the study at any time. The
ethics committee of the University College London approved the251experiment. Data collected in 4 participants (3 females) had to be dis-
carded due to: (n¼ 2) malfunctioning of the apparatus for recording
behavioural responses (see subsection 2.3), (n¼ 1) incomplete data due
to drop out, and (n¼ 1) incorrect positioning of the participant with
respect of the coiler in one of the two sessions.
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The study was designed to deﬁne 2 2 conditions, with reward (high
vs low) and DA modulation (placebo vs DA antagonist risperidone) as
principal variables. All participants were requested to participate in two
sessions: a placebo condition and a second involving DA manipulation,
where we administered 0.5mg of the DA antagonist risperidone. This is
an antipsychotic medication, often used in treatment of schizophrenia,
and selected for this study on the basis of its binding afﬁnity with D2
(3.57 Ki [nM], antagonist) and D1 receptors (244 Ki [nM], antagonist).
Like many other DA antagonists (e.g. asenapine, blonanserin, clozapine,
olanzapine, zotepine), risperidone also interacts with serotonin (5-HT2)
and noradrenaline (α1/2) receptor subtypes (Leucht et al., 2013). Given
the purpose to mimic the effects of reduced DA release, the choice of
risperidone was motivated by the need for an agent that interacts with
both D1 and D2 receptors, having a relatively low level of interactions
with other receptors and most importantly a low human side-effect
proﬁle at the given dosage. Session order was counterbalanced across
subjects and the pharmacological manipulation followed a double blind
procedure. An authorised medical doctor (T.N.) was present during the
study and administered a glass of juice 45min to 1 h prior to the start of
the task in the scanner. The DA antagonist was dispersed in juice in half
the cases. Dosage and schedule, tested in a previous study (Fiore et al.,
2016), was tailored to reduce the incidence of extrapyramidal side ef-
fects, whilst testing the volunteers when the drug was at its maximum
effect (mean peak plasma concentrations of risperidone occurs at about
1 h). An interval of at least 7 days between sessions has been applied.
Each session consisted of three blocks, lasting 10–12min each. Each
block involved 72 trials, organised as follows: 2.5–3.5 s for the ﬁxation
cross, 1.5 s for the reward condition and 2–4 s for the action responseFig. 2. Schematic representation of the computer task. A ﬁxation cross is followed
(“gold coins”) or low reward (“iron coins”), with equal probabilities. Each condition is
presented to the participant on a black screen. This indicates the moment the “grip ac
right hand, until the end of the trial, for 2–4 s. The force applied by a participant is co
moves vertically on the scale. The participants collect points proportionally to the rew
feedback blue line positioned in the “green zone” of the scale.
252(Fig. 2). Trial order was pseudorandomized to alternate between reward
(either 10 points or 1 point per second spent applying the correct force)
and action type. A calibration phase and a short training were required
prior to each session. During calibration participants were asked to apply
a force that they could feel comfortable with for the duration of the entire
task. After the training (150 s circa per 24 trials), the participants were
allowed to repeat the calibration phase if they wished so, but they could
not change these settings after the beginning of the ﬁrst block of trials.
This procedure also allowed the participants to establish a motor memory
for the force to be applied, avoiding learning processes during the actual
task.
The task required participants to apply a force established during the
calibration phase so as to score points and maximise their reward. Either
10 points or 1 points per second were assigned, depending on the reward
condition, proportional to the time spent maintaining a blue bar repre-
senting a live feedback (graphical update: 0.1 s) of the force applied, in a
“green zone”. This target area was marked at the centre of an illustrative
force meter that appeared on the screen at the beginning of each trial
(Fig. 2). The force required to reach the centre of this “green zone” was
set during the calibration. This procedure was conceived as an incentive
to facilitate participants to always apply the same force, independently of
the reward associated with the trial, therefore avoiding force-related
differences in BOLD activity (Pessiglione et al., 2007; Spraker et al.,
2007; Vaillancourt et al., 2004). Participants were aware that the
compensation was computed as £1 for every 125 points and were
reminded they could score up to 40 points per high reward trial, or 4
points per low reward trial.
The experiment was replicated twice for two motor actions. In one
context participants were required to use the right hand on a hand grip
apparatus equipped with pressure sensors. In the second case the sensorsby a symbol indicating the starting trial is characterised by either high reward
followed by the motor part of the task, where a red and green scale-like image is
tion” has to be performed, applying a sustained force on the apparatus, with the
nstantly recorded and reported on screen by means of a horizontal blue line that
ard of the trial, per each second spent applying the correct force, i.e. having the
V.G. Fiore et al. NeuroImage 173 (2018) 249–257were located on a pedal activated with the right foot. Unfortunately, due
to equipment failure, data recorded with the pedal had to be discarded in
the present analysis. More precisely, to the position of the participants in
the scanner (the leg had to be approximately 45 above the pedal) and
the fact that the apparatus itself could be pushed away a few centimetres
during the trials, resulted in the pressure sensors in the pedal to often
confound changes of weight on the foot on the pedal as voluntary motor
actions.
In the analysis of both behaviour and fMRI BOLD activity, repeated
measures ANOVA was used to test the presence of an interaction effect
between the two variables of reward and DA manipulation. Behavioural
analysis focused on the measure of reaction time, calculated as the time
required to apply the rewarded force. The time counter started when a
visual cue for the motor action appeared on the screen and it was stopped
when the participants applied a force within the required range (i.e. the
force feedback system signals the participants that the “green zone” has
been reached). Repeatedmeasures ANOVAwere used to test the presence
of an interaction effect when considering beta values extracted from ten
independent regions of interests (ROI) under the four conditions deﬁned
by the 2 2 design.
fMRI data acquisition and preprocessing
A 3-dimensional sequence with a resolution of 2mmwas chosen for a
3-Tesla MR scanner (Siemens) at the Functional Imaging Laboratory,
Wellcome Trust Centre for Neuroimaging at UCL. Structural imaging was
carried out with a resolution of 1mm, Multi Parametric Maps. Functional
images were acquired with a 3D echo-planar imaging (EPI), ﬂip
angle¼ 90, volume repetition time of 3.5 s, echo time of 30 ms, 52 sli-
ces, Matrix size 96 108, echo spacing of 0.78 ms, transverse orienta-
tion, and a resolution of 2.0 2.0 2.0mm. FMRI data preprocessing
was performed using statistical parametric mapping (SPM12, Wellcome
Department of Imaging Neuroscience). The functional scans were real-
igned to the ﬁrst volume, coregistered to the T1 image, and normalized to
a standard MNI (Montreal Neurological Institute) template. The scans
were only spatially smoothed for the whole brain analysis (¼6mm), but
they were not spatially smoothed for the ROI analysis, due to the small
volumes of the chosen ROIs.
General linear modelling (GLM) of fMRI data
Event-related analyses of the fMRI data were conducted using sta-
tistical parametric mapping (SPM12; Wellcome Department of Imaging
Neuroscience, London, UK). GLM (Friston et al., 1994) was conducted for
the functional scans from each participant by modelling the observed
event-related BOLD signals and regressors to identify the relationship
between the task events and the hemodynamic response. Regressors
related to all events were created by convolving a train of delta functions
representing the sequence of individual events with the default SPM basis
function, which consists of a synthetic hemodynamic response function
composed of two gamma functions (Friston et al., 1994, 1998). We
combined both sessions and concatenated the six total runs to include in
one model the regressors of all 4 conditions from the 2 (drug: placebo
[pla] vs. risperidone [ris]) by 2 (reward: high reward [HR] vs. low
reward [LR]) design: pla-LR, pla-HR, ris-LR, ris-HR. For the whole brain
analysis we time-locked events to the moment of presentation of the
reward symbol, with a duration of zero, so as to test the main effects of
the two variables, independently of the actions performed. For this
analysis, we used a combined threshold of p< .005 with a 50 voxel
extent to highlight signiﬁcant differences (e.g. see: Lieberman and Cun-
ningham, 2009). The use of an extent threshold of 50 voxels does not
imply we used spatial extent as the basis of inference, but rather that we
ignored clusters of 50 voxels or less. For the ROI analysis, we meant to
measure BOLD activity in association with the sustained motor response
of each trial. Thus, the events were time-locked to a time interval having
the visual cue signalling the beginning of motor action as a start and the253end of each trial as the end of the event. Linear contrasts of the parameter
estimates were implemented to identify effects in a within subject
comparison.
Regions of interest
To test our key hypothesis and the predictions of the model, we
focused on the internal and output nuclei of the BG. Participants were
instructed to perform their actions with the right hand, therefore we
expected to ﬁnd the key changes in the encoding of action-state values in
BOLD activity of the left hemisphere, localised in the areas associated
with motor execution. The dorsal segment of both GPe and GPi is
responsible for encoding sensorimotor command selection and execution
(Draganski et al., 2008; Pessiglione et al., 2007; Saga et al., 2017),
therefore we constructed different masks to allow separate analysis for
dorsal and ventral areas of both GPe and GPi, which were analysed
bilaterally for comparison. Finally, we analysed bilateral activation of
SNr, which represents the output nucleus processing mainly information,
such as expected future outcomes, encoded in the ventral cortico-striatal
loop (Draganski et al., 2008; Haber, 2003; Jahanshahi et al., 2015).
The masks for all ROIs were manually deﬁned to account for the
dorsal/ventral separation and to focus only on the SNr, thus excluding
the adjacent dopaminergic area of the SN pars compacta. As a reference
for the nuclei in their entirety, we used recently published and freely
available online atlases of the BG (Smittenaar et al., 2017; Xiao et al.,
2012, 2015, 2017). The sensorimotor section of both GPe and GPi ac-
counts for roughly half of their entire volume (Rodriguez-Oroz et al.,
2009; Romanelli et al., 2005) and the two parts of the GP extend on the
horizontal plane roughly between the values y¼14 and y¼ 7 (GPe)
and y¼11 and y¼ 3 (GPi). Thus we divided dorsal and ventral seg-
ments on the horizontal plane at the value y¼3. Within the nuclei of
interest, we used the ROI to extract signal under the four conditions of the
experimental design (pla-LR, pla-HR, ris-LR, ris-HR). All ROIs were
deﬁned using the software MRIcron and MarsBaR, used jointly with SPM
12.
Results
Simulations and predictions
The neural model illustrates how the nuclei of this simpliﬁed BG
circuit process and encode a constant four dimensional input, putatively
representing four action-state values perceived by the agent. The differ-
ence between high and low values reaching the layer simulating the
striatum is kept constant through. Nonetheless, the representation of
these inputs and the difference between highest and lowest values is
either ampliﬁed or compressed, as a function of DA release (Fig. 1). The
simulations highlight increased value differentiation in the GPe, under
low dopaminergic conditions (Fig. 1G), and in the GPi or SNr, under high
dopaminergic condition (Fig. 1F). Normally, this process of ampliﬁcation
and compression of information in the direct and indirect pathway in-
teracts with the recurrent connectivity of the cortico-thalamo-striatal
circuits, resulting the generation and modulation of the attractor states
in the system (Fiore et al., 2014, 2016; Hauser et al., 2016). In the present
model, we limit our simulations to a feed-forward neural network to
simplify the representation of these neural dynamics. Finally, due to the
design of our DA manipulation, in the present study we focus on the
condition of low DA drive, establishing a comparison with baseline
condition.
Behavioural results
We used repeated measures ANOVA to test the effects reward and DA
manipulation have on the measure of reaction time (Fig. 3). No main
effect was found for any of the two variables (DA antagonist vs placebo:
F ¼ 2.75, p ¼ .11; high vs low reward: F ¼ 1.85 p ¼ .19) with no
Fig. 3. Boxplot representation of the distribution of reaction times under the
conditions of high and low reward (HR and LR, respectively), combined with the
DA drive condition of placebo (pla) or risperidone (ris). Participant 5 is high-
lighted as outlier in terms of RTs recorded under the condition of risperidone.
Fig. 4. Whole brain activity reported with a threshold of p< .005 and a 50
voxel extent. (A) The ﬁrst contrast (coordinates for the image: 22, 24, 6),
between placebo and risperidone condition, shows BOLD activity in the puta-
men (bilateral), caudate (right hemisphere) and orbitofrontal cortex (right
hemisphere). (B) The second contrast (coordinates for the image: 2, 56, 10),
between high and low reward presentation, reveals BOLD activity in the pre-
frontal cortex.
V.G. Fiore et al. NeuroImage 173 (2018) 249–257interaction effect (DA*Reward, F ¼ .31 p ¼ 0.58). The behavioural
analysis highlighted the presence of an outlier (participant 5, Fig. 3) who
was consistently slower than the remaining participants under the con-
dition of risperidone possibly due to a common side effect of the drug,
namely drowsiness,. The slow responses, jointly with the limited time
(2–4 s) available to produce an action, led this participant to miss several
trials (a total of 17 trials against an average of 1.18 for the remaining 19
participants). We consequently report signiﬁcant ROI results with and
without this participant.
fMRI results
We measured the whole brain response to the manipulation of each
variable, testing BOLD signal when contrasting either placebo vs risper-
idone conditions or high vs low reward conditions. By comparison with
the risperidone condition, the placebo condition was found to be asso-
ciated with greater BOLD response in orbitofrontal cortex (right hemi-
sphere) and dorsal striatum (bilateral, p< .005, voxel extent: 50, main
peaks of activity: 22,10,-6; 28,22,-8, and20,8,-8, with right hemisphere
results surviving whole brain correction based on peak height: pFWE-
corr<.001; Fig. 4A). The contrast between high reward and low reward
conditions showed the former was associated with an increase in BOLD
response in the pre-frontal cortex (p< .005, voxel extent: 50, peak of
activity: 2,56,10, which does not survive whole brain correction based
on peak height; Fig. 4B).
For the ROI analysis, the extracted signals under the four conditions
of the experimental design have been used to run 2 by 2 repeated mea-
sures ANOVA for each ROI. We found no main effect for reward
manipulation when considering the selected ROIs in GPe (left dorsal:
F¼ .002, p¼ .96, left ventral: F¼ 1.59, p¼ .22, right dorsal: F¼ .12,
p¼ .73, right ventral: F¼ 2.11, p¼ .16), GPi (left dorsal: F¼ 1.59,
p¼ .22, left ventral F¼ 1.29, p¼ .27, right dorsal: F¼ .97, p¼ .34, right
ventral: F¼ .07, p¼ .80) and SNr (left: F¼ .10, p¼ .75, right: F¼ .21,
p¼ .66). Similarly, we found no signiﬁcant main effect in GPe (left
dorsal: F¼ 1.27, p¼ .27, left ventral: F¼ .002, p¼ .97, right dorsal:
F¼ 2.54, p¼ .13, right ventral: F¼ .72, p¼ .41), GPi (left dorsal: F¼ .02,
p¼ .90, left ventral: F¼ 1.02, p¼ .33, right dorsal: F¼ .004, p¼ .95,
right ventral: F¼ 2.29, p¼ .15) and SNr (left: F¼ .68, p¼ .42, right:
F¼ .01, p¼ .92), when considering the drug manipulation.254Our core hypothesis was a predicted interaction effect in the dorsal
GPe, left hemisphere, involving increased signal in presence of high
values in comparison to low values, under reduced dopaminergic drive
(cf. Fig. 1F). The results support this core prediction, as repeated mea-
sures ANOVA revealed a signiﬁcant interaction effect of the two variables
in the GPe (left dorsal: F¼ 6.53, p¼ .02; if the behavioural outlier is
included: F¼ 3.52, p¼ .076). This interaction effect was limited to the
area responsible for motor execution, and was not found in any of the
remaining GPe ROIs (left ventral: F¼ .00, p¼ .99, right dorsal: F¼ .17,
p¼ .68, right ventral: F¼ .00, p¼ .99). As predicted, extracted beta from
dorsal GPe ROI show the representation of the action-state values in the
task changed direction. Under the placebo condition, BOLD activity was
inversely correlated with reward, as highlighted by the mean within
subjects difference between extracted beta values under HR and LR
conditions (mean differences HR-LR: 0.13, Fig. 5). Conversely, under
risperidone condition, GPe increased its BOLD signal in association with
Fig. 5. Illustration of the maps used for the globus
pallidus ROIs in the left hemisphere (coordinates for
the image: 22, 4, 0) and extracted beta values for
the left dorsal GPe. In the map, dorsal and ventral
GPe are highlighted in red and yellow, respectively,
whereas dorsal and ventral GPi are highlighted in
blue and cyan, respectively. Extracted values are re-
ported as bars with mean and standard error for the
four conditions characterising the experimental
design: high vs low reward (HR - LR) and placebo vs
risperidone (pla - ris). Single data points are reported
(orange) per each condition, linking values extracted
under HR and LR conditions. Repeated measures
ANOVA shows a signiﬁcant interaction effect
(F ¼ 6.53, p ¼ .02), as the mean within subject dif-
ference changes from HR-LR ¼ 0.13, under risper-
idone condition, to HR-LR ¼ þ0.14, under placebo
condition. No main effect is reported for either vari-
able. The beta values are reported after the exclusion
of the behavioural outlier (participant 5).
V.G. Fiore et al. NeuroImage 173 (2018) 249–257high reward (mean difference HR-LR: þ0.14, Fig. 5).
Finally, we analysed the activity in the output nuclei of the BG, testing
for the presence of the opposite interaction effect (cf. Fig. 1G). No sig-
niﬁcant effect was found in the GPi ROIs (left dorsal: F¼ .40, p¼ .53, left
ventral: F ¼ .18, p ¼ .67, right dorsal: F ¼ 1.6, p ¼ .22, right ventral:
F ¼ .21, p ¼ .65). However, we found a signiﬁcant interaction effect
when analysing beta extracted from the right SNr (F ¼ 4.85, p ¼ .04; if
the behavioural outlier is included: F¼ 5.32, p¼ .03), where participants
7 and 11 were outliers under one out of the four conditions (ris-HR and
ris-LR, respectively). No interaction effect was found in the left SNr
(F ¼ .24, p ¼ .63). The analysis shows the presence of a canonical
response for reward encoding in the SNr under placebo condition, where
BOLD activity directly mediates the presence of the expected outcomes
(mean within-subject difference of extracted beta values: HR-
LR ¼ þ0.21, Fig. 6). This representation is inverted under risperidone
condition, as BOLD activity in the SNr shows an inverse correlation with
the reward associated with the trial (mean difference HR-LR: 0.13 for
HR and LR, respectively, Fig. 6).
Discussion
Classic interpretation of the BG function predicts that, under the
condition of low DA drive, increased signalling in the indirect pathway
takes the lead in the competition for the control of the output of the BG,
resulting in motor suppression. Conversely, under high DA drive,
increased signalling in the direct pathway results in motor facilitation
(Albin et al., 1989; Alexander et al., 1986; DeLong, 1990; Smith et al.,
1998). This hypothesis assumes that a speciﬁc role is played by the in-
ternal nuclei of the BG. Most signiﬁcantly: 1) low DA drive and motor
suppression are associated with reduced GPe activity and increased ﬁring255in the output nuclei of GPi and SNr; and 2) high DA drive and motor
facilitation are associated with increased GPe activity and decreased
ﬁring in the output nuclei. This linear mechanistic explanation can ac-
count for a wide variety of motor and cognitive ﬁndings and dysfunc-
tions, such as those related to DA deﬁciency in Parkinson's disease (Obeso
et al., 2014; Rodriguez-Oroz et al., 2009). Nonetheless, shortcomings of
this theory have emerged in new ﬁndings that reveal a complex circuitry
and activity patterns involving the GPe (Bevan et al., 2002; Gittis et al.,
2014; Mallet et al., 2008a), as well as a previously unknown active role
played by the indirect pathway in promoting speciﬁc motor activity
(Nelson and Kreitzer, 2014; Tecuapetla et al., 2014, 2016). These ﬁnd-
ings led us to formulate a new, more comprehensive theoretical frame-
work (Fiore et al., 2015, 2016; Hauser et al., 2016) which states that
cortical information encoding context or state values and the related
sensorimotor contingencies (Azzi et al., 2012; Montague et al., 2006;
O'Doherty, 2014) can be either compressed or ampliﬁed in the BG
pathways as a function of DA release (Fig. 1). This new interpretation
implies activity in the GPe, GPi and SNr should be found to vary as a
function of both DA drive and encoded action-state values.
In this study, we use a simpliﬁed neural architecture to illustrate the
dynamics predicted in our model and we assess with fMRI the two
competing predictions proposed by the classic interpretation and by our
model of the BG, with a speciﬁc focus on the GPe. Namely, the former
predicts a main effect of drug manipulation with stronger activity
localised in the GPe under placebo condition. The latter predicts the
presence of an interaction effect where the difference between the
encoding of high and low action-state values is ampliﬁed under risperi-
done condition. To this end we used a motor task designed to manipulate
two variables for a within-subject analysis. The DA drive was controlled
by administering either placebo or DA antagonist risperidone. The
Fig. 6. Illustration of the map used for the SNr ROI, right hemisphere (co-
ordinates for the image: 11, 13, 15), and extracted beta values for this mask
under the four conditions characterising the experimental design: high vs low
reward (HR - LR) and placebo vs risperidone (pla - ris). Bars with mean and
standard error are overlaid with single data points (orange) per each condition,
where we have linked values extracted under HR and LR conditions. A signiﬁ-
cant interaction effect was found in the right SNr (F ¼ 4.85, p ¼ .04), which was
caused by a change of direction in the mean of the within subject difference: HR-
LR ¼ þ0.21, under risperidone condition, HR-LR ¼ 0.13, under placebo
condition. No main effect is reported for either variable. The beta values are
reported after the exclusion of the behavioural outlier (participant 5). Two
further outliers for the beta values (participants 7 and 11) are also marked with
a red circle.
V.G. Fiore et al. NeuroImage 173 (2018) 249–257action-state value was manipulated by explicit assignment of either low
or high expected rewards to actions initiated, and sustained, for the entire
duration of each trial. Our design involved a preliminary training phase
and the task was then implemented without explicit trial-by-trial feed-
back, so as to avoid or reduce any learning during the experiment. This
design allowed us to interpret the results in terms of how ﬁxed action-
state values (i.e. maximum theoretical rewards associated with a trial)
are encoded in the BG nuclei, independent of learning and plasticity.
Our results show the two variables of DA drive and reward had ex-
pected main effects on striatum and orbitofrontal cortex. However, no
main effect was found for the BOLD activity in any of the nuclei of the BG.
In keeping with the prediction of our model, we found the interaction
between the two variables had a signiﬁcant effect: 1) in the left dorsal
GPe, as the representation of action-state values improves under reduced
DA drive; 2) in the right SNr, where we found the value representation is
inverted when comparing placebo and risperidone conditions. Impor-
tantly, the participants were rewarded when responding with stereo-
typed actions, as changes in motor activity (e.g. pace or intensity of motor
responses) have been reported to cause differences in BOLD responses
(Pessiglione et al., 2007; Spraker et al., 2007; Vaillancourt et al., 2004).
The results show the ability of the participants to apply and maintain a
constant force (within a limited range) did not vary under the different
conditions. Therefore, the task successfully avoids possible confounds,
enabling us to associate variations in BOLD activity with the experi-
mental manipulation of the two variables of interest. The use of ROIs,
which were manually deﬁned for the target regions in the BG on the basis
of previous maps (Smittenaar et al., 2017; Xiao et al., 2012, 2015, 2017),
jointly with the analysis of spatially unsmoothed data, also prevented256possible confounds derived from activity in adjacent areas. The interac-
tion effect predicted in the GPe was found only in the dorsal segment, left
hemisphere, thus in the area expected to encode state values associated
with the execution of motor activity with the right hand (Draganski et al.,
2008; Pessiglione et al., 2007; Saga et al., 2017). Finally, our model
predicted the GPi would be found to express an interaction effect similar
to the SNr, but no signiﬁcant change in BOLD activity was found for the
GPi. In keeping with the model, we hypothesise a condition characterised
by higher than normal DA drive might help highlighting an effect in the
GPi. Further investigations are required to test and possibly validate this
hypothesis.
Despite important limitations, such as an unbalanced gender repre-
sentation and a relatively small sample size, our ﬁndings nevertheless
challenge the common view of the linear interaction between DA release
and information processing in the BG. In particular, by highlighting that
activity in GPe varies as a function of both DA drive and action-state
values, our data offer some support for an alternative model of both
motor and cognitive dysfunctions associated with disrupted striatal DA
release. Further investigation is required to establish an unequivocal link
between changes in activity in the GPe and selection switching or pattern
generation, as has been suggested in recent work (Fiore et al., 2016;
Tecuapetla et al., 2014, 2016; Vicente et al., 2016). This is particularly
important when considering disorders associated with DA dysregulation,
such as Parkinson's disease. The possibility to generate increased motor
switching, as well as the classic motor suppression, grants the model the
required plasticity to simulate different behavioural phenotypes associ-
ated with the same DA biophysical dysfunction.
Conclusions
Our study provides insights into the way action-state values are
encoded in the internal nuclei of the BG and the GPe in particular. Our
results show that changes in mean ﬁeld potentials in the GPe -suggested
by the reported changes in BOLD activity-are not limited to DA manip-
ulations, as it is often assumed. As predicted by our model, action-state
values are encoded in the GPe and their differences are ampliﬁed
under the condition of low dopaminergic release. We hypothesise this
incorrect encoding interferes with the healthy selection process per-
formed in the basal ganglia, under conditions such as Parkinson's disease.
A better understanding of BG dynamics can heavily impact the possibility
to develop treatments for motor disorders, such as deep brain
stimulation.
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